Stem cell therapy in pulmonary hypertension-induced right heart failure reduces right ventricular hypertrophy, dysfunction and remodeling by inhibiting pulmonary arteriolar medial hypertrophy

被引:0
|
作者
Umar, S. [1 ]
Steendijk, P. [1 ]
Wagenaar, G. [1 ]
Schutte, C. [1 ]
Bax, W. [1 ]
Pijnappels, D. [1 ]
Atsma, D. [1 ]
Schalij, M. [1 ]
Van der Wall, E. [1 ]
Van der Laarse, A. [1 ]
机构
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:495 / 495
页数:1
相关论文
共 50 条
  • [1] Intralipid Therapy for Prevention of Pulmonary Hypertension-induced Right Ventricular Failure
    Umar, Soban
    Maltese, Federica
    Matori, Humann
    Iorga, Andrea
    Nadadur, Rangarajan D.
    Partownavid, Parisa
    Rahman, Siamak
    Eghbali, Mansoureh
    CIRCULATION, 2010, 122 (21)
  • [2] RIGHT HEART CATHETERIZATION IN RATS WITH PULMONARY-HYPERTENSION AND RIGHT VENTRICULAR HYPERTROPHY
    ZIMMER, HG
    ZIERHUT, W
    SEESKO, RC
    VAREKAMP, AE
    BASIC RESEARCH IN CARDIOLOGY, 1988, 83 (01) : 48 - 57
  • [3] INCREASED RIGHT VENTRICULAR FUNCTION IN HYPERTENSION-INDUCED HYPERTROPHY
    SEAGREN, SC
    PIGGOTT, WJ
    POOL, PE
    CIRCULATION, 1971, 44 (04) : 125 - &
  • [4] Significance of electrocardiographic right ventricular hypertrophy in patients with pulmonary hypertension with or without right ventricular dysfunction
    Nagai, T.
    Kohsaka, S.
    Murata, M.
    Okuda, S.
    Anzai, T.
    Sato, T.
    Fukuda, K.
    EUROPEAN HEART JOURNAL, 2011, 32 : 443 - 444
  • [5] SIGNIFICANCE OF ELECTROCARDIOGRAPHIC RIGHT VENTRICULAR HYPERTROPHY IN PATIENTS WITH PULMONARY HYPERTENSION WITH OR WITHOUT RIGHT VENTRICULAR DYSFUNCTION
    Nagai, Toshiyuki
    Kohsaka, Shun
    Murata, Mitsushige
    Okuda, Shigeo
    Anzai, Toshihisa
    Sato, Toru
    Fukuda, Keiichi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E149 - E149
  • [6] Significance of Electrocardiographic Right Ventricular Hypertrophy in Patients with Pulmonary Hypertension with or without Right Ventricular Systolic Dysfunction
    Nagai, Toshiyuki
    Kohsaka, Shun
    Murata, Mitsushige
    Okuda, Shigeo
    Anzai, Toshihisa
    Fukuda, Keiichi
    Satoh, Toru
    INTERNAL MEDICINE, 2012, 51 (17) : 2277 - 2283
  • [7] Metabolic Gene Remodeling and Mitochondrial Dysfunction in Failing Right Ventricular Hypertrophy Secondary to Pulmonary Arterial Hypertension
    Gomez-Arroyo, Jose
    Mizuno, Shiro
    Szczepanek, Karol
    Van Tassell, Benjamin
    Natarajan, Ramesh
    dos Remedios, Cristobal G.
    Drake, Jennifer I.
    Farkas, Laszlo
    Kraskauskas, Donatas
    Wijesinghe, Dayanjan S.
    Chalfant, Charles E.
    Bigbee, John
    Abbate, Antonio
    Lesnefsky, Edward J.
    Bogaard, Harm J.
    Voelkel, Norbert F.
    CIRCULATION-HEART FAILURE, 2013, 6 (01) : 136 - +
  • [8] Wnt5a attenuates hypoxia-induced pulmonary arteriolar remodeling and right ventricular hypertrophy in mice
    Jin, Yuling
    Wang, Wang
    Chai, Sanbao
    Liu, Jie
    Yang, Ting
    Wang, Jun
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2015, 240 (12) : 1742 - 1751
  • [9] Incomplete reverse remodeling in aged mice exposed to pulmonary hypertension-induced right ventricular failure
    McNair, Benjamin
    Azmerin, Maria
    Thornburg, Joshua
    Bhaysar, Vaishnavi
    Matthews, Julian
    Bruns, Danielle
    PHYSIOLOGY, 2024, 39
  • [10] Salubrinal attenuates right ventricular hypertrophy and dysfunction in hypoxic pulmonary hypertension of rats
    He, Yun-Yun
    Liu, Chun-Lei
    Li, Xin
    Li, Rui-Jun
    Wang, Li-Li
    He, Kun-Lun
    VASCULAR PHARMACOLOGY, 2016, 87 : 190 - 198